News

ICMR study shows COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well

Bharat Biotech and ICMR Announce Interim Results from Phase 3 trials of COVAXIN®; Demonstrates overall Interim Clinical Efficacy of 78% and 100% efficacy against Severe COVID-19 disease

Read More

Apr 21, 2021

By : Team ABLE

Minister Piyush Goyal launches the Startup India Seed Fund Scheme

Minister says the scheme will Secure seed funding, Inspire innovation, Support transformative ideas, Facilitate implementation, and Start startup revolution. 3,600 startups are expected to benefit from the scheme.

Read More

Apr 20, 2021

By : Team ABLE

“We understand India’s needs,” says the US Government on vaccine’s raw material supply issues

The US Government responds to Serum’s request for allowing raw material and ingredients for Covid-19 vaccines. Mr Adar Poonawalla, CEO, Serum Institute of India (SII) had requested the US President Biden through a tweet asking the US to lift the embargo of raw material exports out of the US to ramp up vaccine production.

Read More

Apr 20, 2021

By : Team ABLE

"Decisive Change" says Serum's Adar Poonawalla On Centre's New Vaccine Policy

"I'd like to applaud Shri Narendra Modi Ji," tweeted Mr Adar C Poonawalla, CEO, Serum Institute of India (SII) after the Central Government announced new Vaccine policy on April 19.

Read More

Apr 20, 2021

By : Team ABLE

Vaccine manufacturers empowered to release up to 50% of their supply to State Govts. and in the open market at a pre-declared price

Government of India announces a Liberalised and Accelerated Phase 3 Strategy of Covid-19 Vaccination from May 1, 2021

Read More

Apr 19, 2021

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights